- Home
- ADTX vs NUWE Comparison
ADTX vs NUWE Comparison
Compare ADTX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- NUWE
- Stock Information
- Founded
- ADTX 2017
- NUWE 1999
- Country
- ADTX United States
- NUWE United States
- Employees
- ADTX N/A
- NUWE N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ADTX Health Care
- NUWE Health Care
- Exchange
- ADTX Nasdaq
- NUWE Nasdaq
- Market Cap
- ADTX 4.9M
- NUWE 3.9M
- IPO Year
- ADTX 2020
- NUWE N/A
- Fundamental
- Price
- ADTX $0.67
- NUWE $3.79
- Analyst Decision
- ADTX
- NUWE
- Analyst Count
- ADTX 0
- NUWE 0
- Target Price
- ADTX N/A
- NUWE N/A
- AVG Volume (30 Days)
- ADTX 342.1K
- NUWE 325.0K
- Earning Date
- ADTX 11-17-2025
- NUWE 11-10-2025
- Dividend Yield
- ADTX N/A
- NUWE N/A
- EPS Growth
- ADTX N/A
- NUWE N/A
- EPS
- ADTX N/A
- NUWE N/A
- Revenue
- ADTX $12,051.00
- NUWE $8,318,000.00
- Revenue This Year
- ADTX $15,768.94
- NUWE $6.53
- Revenue Next Year
- ADTX N/A
- NUWE $51.63
- P/E Ratio
- ADTX N/A
- NUWE N/A
- Revenue Growth
- ADTX N/A
- NUWE N/A
- 52 Week Low
- ADTX $0.67
- NUWE $3.09
- 52 Week High
- ADTX $464.98
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- ADTX 26.68
- NUWE 39.19
- Support Level
- ADTX $0.97
- NUWE $3.09
- Resistance Level
- ADTX $0.77
- NUWE $3.60
- Average True Range (ATR)
- ADTX 0.07
- NUWE 0.23
- MACD
- ADTX -0.02
- NUWE 0.07
- Stochastic Oscillator
- ADTX 1.51
- NUWE 40.52
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.